Global Custom Recombinant Protein Production Services Market, by Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), by End User (Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 3,575.3 million in 2020 and is projected to exhibit a CAGR of 11.2% over the forecast period (2020 – 2027), as highlighted in a new report published by Coherent Market Insights.

Global Custom Recombinant Protein Production Services Market - Impact of Coronavirus (COVID-19) Pandemic

Following the COVID-19 outbreak in December 2019, the virus has spread to more than 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in more than 29.6 million infected individuals worldwide as of September 2020. The COVID-19 pandemic has affected the global economy in three main ways; by directly affecting production and demand, by negatively impacting the supply chain and market disruption, and through its financial impact on firms and financial markets. Nationwide lockdowns in various countries such as Italy, Spain, U.K., the U.S., Australia, India, and others have disrupted daily life and activities.

Moreover, severe economic crisis and broken supply chain (due to Covid 19 lockdown) of bioprocessing industry is a major issue faced by bioprocessing companies in every country across the globe. The pandemic has negatively impacted the bioprocessing industry in terms of supply and demand of biologics. As a result, the global recombinant protein production services market growth is also expected to witness a slowdown.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2737

The slowdown of pharma, biopharma, and biotech companies’ manufacturing processes have also impacted demand for recombinant protein production services.

Browse 37 Market Data Tables and 29 Figures spread through 190 Pages and in-depth TOC on ‘Custom Recombinant Protein Production Services Market’- Global Forecast to 2027, by Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), by End User (Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

The market players are focused on launching facilities to increase production capacity and expand their offerings and services, which is expected to boost the market growth. For instance, in February 2018, Lakepharma, Inc. established a new facility in Massachusetts to offer fully integrated contract development and manufacturing organization (CDMO) services, thereby providing end-to-end services to partners and clients. Similarly, in February 2018, Lakepharma, Inc. launched LakePharma MicroBiomanufacturing Center in Hopkinton, Massachusetts to enhance its ability to offer product development and manufacturing.

Moreover, increasing expenditure on research and development is expected to boost the market growth. For instance, according to the National Bureau of Statistics, February 2018, China’s expenditure on research and development increased by 11.6% in 2017 from 10.6% in 2016 reaching to US$ 280 Bn in 2017.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/custom-recombinant-protein-production-services-market-2737

Furthermore, key players in the market are focused on adopting strategies such as collaborations and acquisitions to enhance their service offerings. For instance, in 2017, Eurofins acquired Villapharma Research SL based in Spain to expand its portfolio of services into comprehensive offering and further strengthen its service proposition for the pharmaceutical and biotech industries.

Key Takeaways of the Custom Recombinant Protein Production Services Market:

The global custom recombinant protein production services market is expected to exhibit a CAGR of 11.2% over the forecast period. This is owing to advancements in bioreactor systems that have reduced production time for recombinant proteins.

Among expression systems, the mammalian segment is estimated to hold dominant position in the custom recombinant protein production services market in 2020. This is owing to the ability of mammalian expression to offer optimized transient system for rapid yield of protein production.

Among end users, biotechnology and pharmaceutical companies segment is estimated to hold dominant position in the custom recombinant protein production services market in 2020, owing to increasing number of research and development activities. According to Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member companies invested an estimated US$ 58.8 billion in research and development in 2015, which was the majority of all biopharmaceutical R&D spending in the U.S.

Key players operating in the global custom recombinant protein production services market include GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, Sino Biological Inc., and SignalChem Lifesciences Corporation

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2737

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737